You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
信立泰(002294.SZ):2020年度淨利預降89.75%-92.94%
格隆匯 01-29 21:41

格隆匯 1 月 29日丨信立泰(002294.SZ)披露2020年度業績預吿,預計2020年度歸屬於上市公司股東的淨利潤5050.01萬元–7327.46萬元,同比下降89.75%-92.94%;扣除非經常性損益後的淨利潤329.60萬元–478.24萬元,同比下降99.26%-99.49%。業績變動原因如下:

1、聯盟地區帶量採購,氯吡格雷產品單價進一步下降,受到聯盟地區未中標影響,泰嘉收入同比下降。

2、新冠疫情影響,上半年醫院住院量、門診量、手術量急劇下降,信立坦等新產品的准入、推廣受阻;擇期手術量的下降,造成術中用藥——泰加寧,銷量下滑,“Alpha Stent®藥物洗脱冠脈支架”銷售推廣亦受到影響。下半年情況已逐漸好轉,但全年的營收情況低於年初預期。

3、冠脈支架全國集採,“Alpha Stent®藥物洗脱冠脈支架”未中標國家冠脈支架集中帶量採購,公司判斷全資子公司蘇州桓晨醫療科技有限公司(下稱“蘇州桓晨”)存在商譽減值跡象。為客觀、公正反映資產價值和財務狀況,報吿期內,公司根據《企業會計準則》、《會計監管風險提示第8號——商譽減值》等規定,對蘇州桓晨計提商譽減值準備2.83億元。計提完成後,蘇州桓晨的商譽賬面價值為0元(本次計提商譽減值準備未經會計師事務所審計,最終數據以會計師事務所審計的財務數據為準)。

4、報吿期內,公司加大創新研發投入,多項在研項目獲批臨牀並處於不同研發階段,重點項目進展順利,為未來長遠發展提供源動力;同時,加大創新產品的推廣力度,創新產品的收入及市場佔有快速增長,逐步成為公司業績的主要增長點。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account